Gastroenterology, CentraCare Hospital , USA.
Gastroenterology, CentraCare Hospital, USA.
Rev Esp Enferm Dig. 2023 Nov;115(11):648-649. doi: 10.17235/reed.2022.9218/2022.
A 56-year-old female developed deep jaundice months after struggling with critical illness due to COVID-19, requiring hemodialysis and tracheostomy. Lab tests included alkaline phosphatase 1,574 U/l, total bilirubin 11 mg/dl, alanine transaminase (ALT) 88 U/l and aspartate aminotransferase (AST) 101 U/l. Baseline liver tests were normal before illness. Anti-nuclear antibodies (ANA), IgG4 level and viral hepatitis were negaCritical illness cholangiopathy resulted in secondary sclerosing cholangitis. In this case, it is unclear whether the patient suffered these changes as a direct cause of COVID-19 or as a result of critical illness cholangiopathy. The overall prognosis is guarded given its progressive nature and likely need for liver transplantation.tive.
一位 56 岁女性在因 COVID-19 而患重病并接受血液透析和气管切开术后数月出现深度黄疸。实验室检查包括碱性磷酸酶 1574U/L,总胆红素 11mg/dl,丙氨酸转氨酶(ALT)88U/l 和天冬氨酸转氨酶(AST)101U/l。疾病前的基线肝功能正常。抗核抗体(ANA)、IgG4 水平和病毒性肝炎均为阴性。
重症疾病相关性胆管病导致继发性硬化性胆管炎。在这种情况下,尚不清楚患者的这些变化是 COVID-19 的直接原因还是重症疾病相关性胆管病的结果。鉴于其进行性和可能需要进行肝移植,总体预后较差。